Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin Metastases

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01421017
Recruitment Status : Active, not recruiting
First Posted : August 22, 2011
Last Update Posted : February 7, 2018
National Cancer Institute (NCI)
Information provided by (Responsible Party):
New York University School of Medicine